Skip to main content

DOBUTAMINE

NDC 51662-1337 · HF Acquisition Co LLC, DBA HealthFirst

Generic nameDOBUTAMINE
Dosage formINJECTION, SOLUTION, CONCENTRATE
RouteINTRAVENOUS
Active ingredient(s)DOBUTAMINE HYDROCHLORIDE
Strength12.5 mg/mL
Pharmacologic classAdrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]
Marketing categoryANDA

Packages

51662-1337-1 — 20 mL in 1 VIAL, SINGLE-DOSE (51662-1337-1)

51662-1337-3 — 10 POUCH in 1 CASE (51662-1337-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1337-2) / 20 mL in 1 VIAL, SINGLE-DOSE

Billed under HCPCS

J1250 — Injection, dobutamine hydrochloride, per 250 mg Medicare Part B payment limit (ASP + 6%): $7.69

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0143-9141 — Dobutamine, 0338-1073 — Dobutamine Hydrochloride, 0338-1075 — Dobutamine Hydrochloride, 0338-1077 — Dobutamine Hydrochloride, 0409-0025 — Dobutamine in Dextrose, 0409-0151 — Dobutamine in Dextrose, 0409-1100 — Dobutamine in Dextrose, 0409-2344 — DOBUTAMINE, 51662-1330 — DOBUTAMINE, 51662-1566 — DOBUTAMINE HYDROCHLORIDE, 51662-1664 — DOBUTAMINE IN DEXTROSE, 51662-1697 — DOBUTAMINE IN DEXTROSE, 51662-1705 — DOBUTAMINE IN DEXTROSE, 70436-203 — dobutamine

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.